Presentation of the activity of the IBMM
Biomolecules are natural complex organic molecules (consisting of carbon and hydrogen, but also oxygen, nitrogen, sulphur, etc…) which can only be found in living organisms, since they are formed by the organism properly speaking. These are for instance molecules like DNA, RNA, proteins, sugars, lipids… The « Institute des Biomolécules Max Mousseron » (IBMM or UMR5247 CNRS-University of Montpellier 1-University of Montpellier 2), whose director is professor Jean Martinez, is a research institute of international renown and one of the four Founder Institutes of the Balard Chemistry Pole of Montpellier. The research activities concentrate on essential biomolecules such as lipids, nucleosides, nucleotides and nucleic acids, peptides and proteins, glycosides, biopolymers, prebiotic molecules and fluorinated molecules. The research programmes conducted on biomolecules concern their design, their synthesis and their pharmacology. These biomolecules and their families of compounds are used as basic molecules in pharmacology for studying their related physiological and pathological mechanisms, they are also the essential precursor molecules for future medications. The research activities of the IBMM are situated at the junction of chemistry and biology, they aim to study and understand the action mechanisms of biomolecules and the treatment of human and animal pathologies (infectious, cardiovascular, degenerative pathologies, cancer…) with applications in tomorrow’s molecular medicine. Simultaneously, the applications of biomolecules cover vast fields such as cosmetology, agrofood industry, veterinary industry and environment-friendly agrochemistry and within a sustainable development framework (green chemistry). The assets of the IBMM lie in the diversity of the skills and in the complementarity of the different teams of the Institute, in the international recognition of the teams, in the numerous academic and industrial collaborations developed and in its technology valorisation, innovation and transfer actions. The IBMM is also an attractive centre for future junior researchers thanks to the diverse tuitions and training periods opportunities it offers on the basis of its expertise capacities and of its know-how in terms of design, analysis and discovery of the future medications which characterise the Montpellier site in the field of biomolecules.
Toutes les versions de cet article : [English] [français]
Dans la même rubrique :